Yes, of course, anything that increases the number of T-cells is going to require more leronlimab to prevent HIV entry into a T-cell; however, I really fail to see what that has to do with suppressing influenza viruses or mitigating the typical sequelae?

Again, I am not unimpressed with leronlimab; in fact, I’m extremely impressed. I just think we should only posit indications that have some proven basis in science or at least some reasonable hypothesis that could be tested.